Leila Arabi

1.6k total citations
36 papers, 1.2k citations indexed

About

Leila Arabi is a scholar working on Biomaterials, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Leila Arabi has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Biomaterials, 14 papers in Molecular Biology and 11 papers in Biomedical Engineering. Recurrent topics in Leila Arabi's work include Nanoparticle-Based Drug Delivery (17 papers), RNA Interference and Gene Delivery (10 papers) and Nanoplatforms for cancer theranostics (10 papers). Leila Arabi is often cited by papers focused on Nanoparticle-Based Drug Delivery (17 papers), RNA Interference and Gene Delivery (10 papers) and Nanoplatforms for cancer theranostics (10 papers). Leila Arabi collaborates with scholars based in Iran, United Kingdom and United States. Leila Arabi's co-authors include Mahmoud Reza Jaafari, Ali Badiee, Fatemeh Mosaffa, Marzieh Mohammadi, Mona Alibolandi, Seyedeh Hoda Alavizadeh, Mohammad Mashreghi, Christian Ruiz, Luca Quagliata and Elaheh Mirhadi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Leila Arabi

34 papers receiving 1.2k citations

Peers

Leila Arabi

BIOMA

ONCOL

Chunai Gong China

Aihua Wu China

Pengxuan Zhao China

Meghna Mehta United States

Ranganayaki Muralidharan United States

Kanokwan Sansanaphongpricha Thailand

Golam Kibria Japan

Janani Panneerselvam United States

Wenxian Guan China

Chunai Gong China

Leila Arabi

844 ×1.2

403 ×1.0

414 ×1.1

BIOMA

611 ×1.9

138 ×0.7

ONCOL

Citations per year, relative to Leila Arabi Leila Arabi (= 1×) peers Chunai Gong

Countries citing papers authored by Leila Arabi

Since Specialization

Citations

This map shows the geographic impact of Leila Arabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leila Arabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leila Arabi more than expected).

Fields of papers citing papers by Leila Arabi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leila Arabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leila Arabi. The network helps show where Leila Arabi may publish in the future.

Co-authorship network of co-authors of Leila Arabi

This figure shows the co-authorship network connecting the top 25 collaborators of Leila Arabi. A scholar is included among the top collaborators of Leila Arabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leila Arabi. Leila Arabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kamali, Hossein, Leila Arabi, Vahideh Mohammadzadeh, et al.. (2025). Thermosensitive hydrogel containing liposomal nanoparticles of deferoxamine and curcumin: In vitro evaluation and diabetic wound healing effect in rats. International Journal of Pharmaceutics. 685. 126227–126227.

Hosseinikhah, Seyedeh Maryam, Farshad Mirzavi, Leila Arabi, et al.. (2025). Ultrasound-assisted efficient targeting of doxorubicin to the tumor microenvironment by lyso-thermosensitive liposomes of varying phase transition temperatures. European Journal of Pharmaceutical Sciences. 206. 107024–107024.

Rahiman, Niloufar, et al.. (2025). Lipid nanoparticle (LNP) mediated mRNA delivery in neurodegenerative diseases. Journal of Controlled Release. 381. 113641–113641. 7 indexed citations

Alavizadeh, Seyedeh Hoda, et al.. (2024). Chemo-immunotherapy by nanoliposomal epacadostat and docetaxel combination to IDO1 inhibition and tumor microenvironment suppression. International Immunopharmacology. 137. 112437–112437. 6 indexed citations

Mirhadi, Elaheh, Anis Askarizadeh, Mohammad Mashreghi, et al.. (2024). The impact of phospholipids with high transition temperature to enhance redox-sensitive liposomal doxorubicin efficacy in colon carcinoma model. Chemistry and Physics of Lipids. 261. 105396–105396. 7 indexed citations

Askarizadeh, Anis, Mohammad Mashreghi, Elaheh Mirhadi, et al.. (2023). Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy. Cancer Nanotechnology. 14(1). 18–18. 36 indexed citations

Mehrabian, Amin, Mohammad Mashreghi, Anis Askarizadeh, et al.. (2023). The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre‐insertion and post‐insertion methods for brain delivery in normal mice. IET Nanobiotechnology. 17(2). 112–124. 13 indexed citations

Rahiman, Niloufar, Parvin Zamani, Leila Arabi, et al.. (2023). Novel liposomal glatiramer acetate: Preparation and immunomodulatory evaluation in murine model of multiple sclerosis. International Journal of Pharmaceutics. 648. 123620–123620. 4 indexed citations

Badiee, Ali, et al.. (2023). Liposomal celecoxib combined with dendritic cell therapy enhances antitumor efficacy in melanoma. Journal of Controlled Release. 354. 453–464. 16 indexed citations

10.

Rahiman, Niloufar, et al.. (2023). Targeting fibroblast activation protein (FAP): advances in CAR-T cell, antibody, and vaccine in cancer immunotherapy. Drug Delivery and Translational Research. 13(7). 2041–2056. 48 indexed citations

11.

Arabi, Leila, Mehdi Montazer, Anis Askarizadeh, et al.. (2023). The effect of m2 peptide targeted nanoliposomes containing crocin on induction of phenotypic change in tumor macrophages to M1 state. Life Sciences. 330. 121992–121992. 5 indexed citations

12.

Karbasforooshan, Hedyieh, et al.. (2022). Silymarin as a preventive or therapeutic measure for chemotherapy and radiotherapy-induced adverse reactions: a comprehensive review of preclinical and clinical data. European Journal of Clinical Pharmacology. 79(1). 15–38. 14 indexed citations

13.

Rahiman, Niloufar, Marzieh Mohammadi, Seyedeh Hoda Alavizadeh, et al.. (2022). Recent advancements in nanoparticle-mediated approaches for restoration of multiple sclerosis. Journal of Controlled Release. 343. 620–644. 19 indexed citations

14.

Mohammadi, Marzieh, Leila Arabi, & Mona Alibolandi. (2020). Doxorubicin-loaded composite nanogels for cancer treatment. Journal of Controlled Release. 328. 171–191. 108 indexed citations

15.

Mirhadi, Elaheh, Mohammad Mashreghi, Mahdi Faal Maleki, et al.. (2020). Redox-sensitive nanoscale drug delivery systems for cancer treatment. International Journal of Pharmaceutics. 589. 119882–119882. 96 indexed citations

16.

Mansourian, Arash, et al.. (2017). Checklist development for assessing the dental students\' clinical skills in oral and maxillofacial medicine course and comparison with global rating. SHILAP Revista de lepidopterología. 1 indexed citations

17.

Razazan, Atefeh, Javad Behravan, Atefeh Arab, et al.. (2017). Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model. PLoS ONE. 12(10). e0185099–e0185099. 46 indexed citations

18.

Ebrahimi, Zahra, Ali Badiee, Mercedeh Mansourian, et al.. (2016). Poly (I:C)-DOTAP cationic nanoliposome containing multi-epitope HER2-derived peptide promotes vaccine-elicited anti-tumor immunity in a murine model. Immunology Letters. 176. 57–64. 31 indexed citations

19.

Jalali, Seyed Amir, Ali Badiee, Mercedeh Mansourian, et al.. (2016). Stimulation of Tumor-Specific Immunity by p5 HER-2/neu Generated Peptide Encapsulated in Nano-liposomes with High Phase Transition Temperature Phospholipids. Current Drug Delivery. 14(4). 492–502. 15 indexed citations

20.

Quagliata, Luca, Matthias S. Matter, Salvatore Piscuoglio, et al.. (2013). Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology. 59(3). 911–923. 373 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact